Diagnosis and management of tumor lysis syndrome. Issue 3 (3rd May 2020)

• Record Type: Journal Article
• Authors: Puri, Isha; Sharma, Deep; Gunturu, Krishna S.; Ahmed, Andaleeb A.
• Is Part Of: Journal of community hospital internal medicine perspectives. Volume 10:Issue 3(2020)
• Page Start: 269
• Page End: 272
• Publication Date: 2020-05-03
• Subjects: Tumor lysis syndrome -- cancer -- tumor -- uric acid -- malignancy; Internal medicine -- Periodicals; Hospitals -- Periodicals; Hospitals, Community; Internal Medicine; Hospitals; Internal medicine; Periodicals; Periodicals; 610
• DOI: 10.1080/20009666.2020.1761185
• Languages: English
• ISSNs: 2000-9666

Abstract

ABSTRACT: Tumor lysis syndrome (TLS) is an oncological emergency characterized by a classic tetrad of hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. Risk assessment and prophylactic therapy is critical in preventing this oncological emergency. Treatment of established TLS involves aggressive hydration, electrolyte management, and the use of hypouricemic agents.